Sagimet Biosciences Inc.: Sagimet Biosciences Announces Pres

Sagimet Biosciences, a clinical-stage biotechnology company focused on developing a portfolio of internally discovered, selective fatty acid synthase (FASN) inhibitors, announced today that it will present

Related Keywords

China , California , United States , San Diego , London , City Of , United Kingdom , Kostenloser Wertpapierhandel , Sagimet Biosciences , Susan Kinkead , Rohit Loomba , University Of California , Sagimet Biosciences Inc , Research Center , International Liver Congress , European Association , Sagimet , Iosciences , Nnounces , Presentation , Dditional , Hase , Data , Denifanstat , Identifying , Predictive , Etabolic , Signature , Cash , Patients , Asl , Nternational , Liver , Congress , 022 ,